Go to the list of all blogs
Arthur Evans's Avatar
published in Blogs
Jul 15, 2026
Aehr Test Systems (AEHR) Delivers Record Bookings and Returns to GAAP Profitability in Fiscal 2026 Q4

Aehr Test Systems (AEHR) Delivers Record Bookings and Returns to GAAP Profitability in Fiscal 2026 Q4

Key Takeaways

  • Aehr Test Systems reported fiscal 2026 fourth-quarter revenue of $18.8 million, up from $14.1 million in the prior-year period.
  • GAAP net income reached $1.4 million, or $0.04 per diluted share, compared to a net loss of $2.9 million, or $0.10 per diluted share, a year earlier.
  • Non-GAAP net income was $3.6 million, or $0.11 per diluted share.
  • Quarterly bookings hit a record $60.7 million, reflecting robust demand for wafer-level and package-level burn-in systems.
  • The company highlighted strong AI and data center infrastructure demand as a key driver of results.
  • Full-year fiscal 2026 revenue guidance was reaffirmed on the high end of the previously stated range.

Earnings Context and Why It Matters

Aehr Test Systems specializes in test and burn-in solutions for semiconductors, with particular exposure to silicon carbide and advanced packaging for AI processors. The fiscal 2026 fourth quarter marked the end of the company’s fiscal year on May 29, 2026. Investors closely monitor these results because Aehr’s revenue can fluctuate with large system orders from hyperscale customers. Recent quarters showed volatility tied to customer order timing, making the latest report a key indicator of demand trends in the AI infrastructure supply chain and the company’s path toward sustained profitability. To get a quick sense of how AEHR compares within the broader semiconductor equipment group, I ran a scan using Tickeron’s AI Screener.

Reported Results

Aehr Test Systems delivered fiscal 2026 fourth-quarter revenue of $18.8 million, an increase from $14.1 million in the same quarter of fiscal 2025. GAAP net income totaled $1.4 million, or $0.04 per diluted share, reversing a prior-year GAAP net loss of $2.9 million, or $0.10 per diluted share. Non-GAAP net income, which excludes stock-based compensation and other items, reached $3.6 million, or $0.11 per diluted share. Quarterly bookings set a new record at $60.7 million. The company also provided updates on its full-year performance and noted that fiscal 2026 revenue is expected to land on the high side of the previously guided $45 million to $50 million range.

Market Reaction and Investor Sentiment

Shares of AEHR moved higher following the July 14, 2026, earnings release, driven by the record bookings figure and the return to GAAP profitability. Investors focused on the strong book-to-bill ratio and visibility into future revenue from AI-related demand. Sentiment heading into the report had been cautious amid prior-quarter variability, but the positive surprise on bookings helped shift focus toward growth prospects in the semiconductor test equipment sector.

Forward Outlook and Key Factors to Monitor

Investors will watch how Aehr converts its elevated backlog into recognized revenue over the coming quarters. The company expects fiscal 2026 second-half revenue between $25 million and $30 million, with non-GAAP net loss per diluted share between $(0.09) and $(0.05). Continued strength in orders for package-level burn-in systems serving custom AI processors remains a central theme.

Management reiterated expectations for full-year fiscal 2026 revenue to finish on the high end of the $45 million to $50 million range. Key areas to monitor include follow-on production orders from the lead hyperscale customer, progress on silicon carbide customer expansions, and any updates to fiscal 2027 guidance during future earnings calls.

Broader industry dynamics, such as capital spending trends among semiconductor manufacturers and hyperscale data center operators, will also influence Aehr’s trajectory. Margin performance and the timing of large system deliveries are additional factors that could affect quarterly results.

Enhancing Research with Tickeron’s AI Tools

One thing that stands out when reviewing results like these is how much faster pattern and signal analysis becomes with the right tools. I often turn to Tickeron’s AI Screener to filter stocks by industry, technical indicators, and performance metrics. It helps surface comparable names or spot broader trends without manually combing through dozens of charts. In my view, incorporating an AI-driven screener into the workflow adds efficiency when evaluating companies exposed to AI infrastructure spending, though it remains just one part of a broader review process.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: AEHR

Contributor

Financial writer and active order flow futures trader with a focus on fundamental analysis, macroeconomic factors, and equity research. I make in-depth blogs on stocks and ETFs, bridging the gap between raw market data and real-world trading decisions.


AEHR sees MACD Histogram crosses below signal line

AEHR saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on August 21, 2026. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 37 instances where the indicator turned negative. In of the 37 cases the stock moved lower in the days that followed. This puts the odds of a downward move at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 10-day RSI Indicator for AEHR moved out of overbought territory on August 18, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 42 similar instances where the indicator moved out of overbought territory. In of the 42 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Momentum Indicator moved below the 0 level on August 21, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on AEHR as a result. In of 84 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where AEHR declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

AEHR broke above its upper Bollinger Band on August 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.

AEHR moved above its 50-day moving average on August 03, 2026 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for AEHR crossed bullishly above the 50-day moving average on August 11, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a +2 3-day Advance, the price is estimated to grow further. Considering data from situations where AEHR advanced for three days, in of 277 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 251 cases where AEHR Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 65, placing this stock better than average.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. AEHR’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (15.129) is normal, around the industry mean (8.019). P/E Ratio (19.449) is within average values for comparable stocks, (159.406). AEHR's Projected Growth (PEG Ratio) (0.000) is very low in comparison to the industry average of (1.475). AEHR has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.006). P/S Ratio (62.500) is also within normal values, averaging (33.263).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

Notable companies

The most notable companies in this group are Lam Research Corp (NASDAQ:LRCX), Applied Materials (NASDAQ:AMAT), KLA Corporation (NASDAQ:KLAC), Teradyne (NASDAQ:TER), Ambarella (NASDAQ:AMBA).

Industry description

The electronic production equipment industry makes equipment used to produce semiconductors. Such equipment includes wafer fabrication, plasma etching and photo-resist processing equipment. The industry also makes chemical vapor deposition processing systems and photomasks, which are high-purity quartz plates that contain patterns to define integrated circuits layouts. Applied Materials, Inc., Lam Research Corporation, and KLA-Tencor Corporation are examples of electronic production equipment manufacturing companies.

Market Cap

The average market capitalization across the Electronic Production Equipment Industry is 63.51B. The market cap for tickers in the group ranges from 555.66K to 676.06B. ASML holds the highest valuation in this group at 676.06B. The lowest valued company is AVSR at 555.66K.

High and low price notable news

The average weekly price growth across all stocks in the Electronic Production Equipment Industry was -10%. For the same Industry, the average monthly price growth was 70%, and the average quarterly price growth was 74%. ACMR experienced the highest price growth at -1%, while SMTK experienced the biggest fall at -98%.

Volume

The average weekly volume growth across all stocks in the Electronic Production Equipment Industry was -12%. For the same stocks of the Industry, the average monthly volume growth was 7% and the average quarterly volume growth was -59%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 64
P/E Growth Rating: 34
Price Growth Rating: 48
SMR Rating: 73
Profit Risk Rating: 64
Seasonality Score: -27 (-100 ... +100)
View a ticker or compare two or three
AEHR
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a manufacturer of burn-in and test equipment for semiconductor manufacturing

Industry ElectronicProductionEquipment

Profile
Details
Industry
Electronic Production Equipment
Address
400 Kato Terrace
Phone
+1 510 623-9400
Employees
136
Web
https://www.aehr.com
Interact to see
Advertisement
Quantum Computing Inc. completed a $110 million acquisition of Luminar Semiconductor on February 2, significantly strengthening its photonics and manufacturing capabilities. Shares have traded with elevated volatility, peaking near $12.70 in mid-January before retreating to the $9 range amid heavy volume.
ERII shares have remained resilient, trading near $15.47 ahead of Q4 and full-year 2025 earnings scheduled for February 25, 2026. Q3 2025 results exceeded expectations, with revenue of $32 million and EPS of $0.07, despite year-over-year declines tied to project timing.
Liberty Broadband Corporation (LBRDA) has experienced pronounced swings in recent weeks, touching multiyear lows before staging a sharp recovery. The stock continues to trade within a wide 52-week range, closely tied to the value of its Charter Communications stake and investor expectations around the proposed merger.
Apollo Global Management (APO), a leading alternative asset manager, reports Q4 and full-year 2025 results on February 9, 2026, before the market opens. The firm has delivered a year of strong growth, with AUM expanding on record inflows exceeding $200 billion and origination surpassing $300 billion.
Arm Holdings (ARM) shares have demonstrated resilience in recent sessions, rebounding after an initial earnings-related pullback and stabilizing near technical support levels. While smartphone-related headwinds tied to memory shortages pressured sentiment, momentum in AI-driven data center royalties helped restore confidence.
Shell plc (SHEL) reported Q4 2025 adjusted earnings of $3.3 billion, below expectations due to weaker oil prices and non-cash tax charges. Full-year adjusted earnings reached $18.5 billion, supported by strong LNG and upstream operations. A 4% dividend increase to $0.372 per share and a new $3.5 billion buyback program reinforce capital return commitments.
Linde (LIN) reported Q4 2025 adjusted EPS of $4.20, topping estimates, with full-year revenue reaching $34 billion. 2026 EPS guidance of $17.40–$17.90 implies 6–9% growth, supported by a record $10 billion project backlog.
ConocoPhillips (COP) reported Q4 2025 adjusted EPS of $1.02, missing estimates due to weaker oil prices. Full-year adjusted earnings totaled $7.7 billion, with $19.9 billion in operating cash flow. Shares have gained more than 10% in recent weeks, supported by analyst upgrades and sector momentum.
Intercontinental Exchange (ICE) has navigated recent market volatility while remaining within its 52-week range. Broader weakness in financial data and exchange operators has created short-term pressure, but ICE’s diversified business model continues to provide stability.
Verisk Analytics (VRSK) delivered Q4 2025 revenue of $779 million, up 5.9% year over year, with adjusted EPS of $1.82, beating expectations. Booz Allen Hamilton (BAH) reported Q3 FY2026 revenue of $2.62 billion, down 10.2% year over year, but adjusted diluted EPS climbed 14% to $1.77, well above estimates.
(OMC) Omnicom’s fourth-quarter report, released February 18, 2026, marked its first earnings update incorporating results from Interpublic Group (IPG), acquired on November 26, 2025. The combination created the world’s largest marketing services firm by revenue, a significant milestone as the advertising industry consolidates and adapts to digital transformation.
Copart (CPRT) is set to report fiscal Q2 2026 earnings on February 19, 2026, after market close. Consensus calls for EPS of $0.39–$0.40 and revenue of $1.15–$1.18 billion. Global Payments (GPN) posted Q4 2025 adjusted EPS of $3.18, in line with expectations, and adjusted net revenue of $2.32 billion, up 6% in constant currency (excluding dispositions). Thomson Reuters (TRI) delivered Q4 2025 adjusted EPS of $1.07 and revenue of $2.01 billion, up 5% year over year, supported by recurring subscription growth.
Unilever PLC (UL) leads year-to-date performance with a 12.61% gain, ahead of Diageo plc (DEO) at 9.90% and Keurig Dr Pepper Inc. (KDP) at 4.27%. DEO offers the highest dividend yield at 4.35%, compared with KDP (3.16%) and UL (2.97%). All three stocks carry low betas—DEO (0.18), UL (0.24), and KDP (0.35)—highlighting their defensive characteristics.
Q1 Fiscal 2026 Results: Revenue of $333M and adjusted EBITDA of $50M (15% margin), exceeding analyst expectations. FY2026 Guidance Raised: Adjusted EBITDA now projected at $225M, with revenue reaffirmed near $1.5B. EV Backlog Growth: 855 electric buses worth $277M, highlighting robust demand supported by EPA clean bus funding.
IBM fell over 10% today mainly because a new AI tool from Anthropic is seen as a direct threat to IBM’s lucrative COBOL modernization and consulting business, triggering worries that key legacy‑modernization revenue will be automated away.
Today’s drop is mainly about competitive positioning and future growth expectations, not an immediate collapse of current Wegovy/Ozempic sales, but it signals that Novo may not have the strongest next‑wave obesity drug versus Eli Lilly, which is why the stock sold off so sharply.
RNG (RingCentral) dropped over 12% today mainly as a sharp pullback after a very steep recent run‑up driven by upbeat Q4 results, guidance, and capital‑return news, with profit‑taking amplified by valuation concerns and a weak broader tech tap
Fundamentally, the latest public guidance is still for rapid growth and profitability, but today’s drop reflects a reset of sentiment and valuation rather than a brand‑new deterioration in those targets. For investors, the key question is whether the current price appropriately reflects execution risk, competition in diagnostics, and macro volatility after the guidance‑driven rally and subsequent reversal.
TNC (Tennant Company) is down more than 25% today because it reported a very large earnings and revenue miss for Q4 2025, blamed on serious ERP rollout problems and weaker demand, and guided to a slower‑than‑hoped recovery in 2026.
XMTR (Xometry) is down more than 21% today because, despite reporting record growth and an earnings beat, the company announced a CEO transition and investors used the news to take profits after a big prior run‑up, with heavy short interest amplifying the drop.